Ahmed Naqvi, MBBS, DCH, MCPS, MRCP
The Hospital for Sick Children
Section Head, In-Patient Hematology/Oncology Unit
University of Toronto
Alternate Contact: Marta Vila
Alternate Phone: (416) 813-7654 ext. 203297
Alternate Fax: (416) 813-5327
Alternate e-mail: email@example.com
Dr. Ahmed Naqvi joined the staff at The Hospital for Sick Children in 2001. Dr. Naqvi received his undergraduate and post graduate training in paediatrics in Pakistan. He has memberships in the discipline of paediatrics from the College of Physicians and Surgeons of Pakistan (MCPS) and the Royal Colleges of Physicians of UK (MRCP). He completed a clinical fellowship in Paediatric Haematology and Oncology at SickKids from 1995 to 1998.
Prior to joining SickKids, Dr. Naqvi worked as a consultant Paediatric Haematologist and Oncologist and an Associate Professor at The Aga Khan University (AKU) in Karachi, Pakistan. He was the Director of the Pediatric Residency training Program at AKU for more than three years. He was instrumental in developing pediatric hematology and oncology service at AKU, which later developed into a full section.
Dr. Naqvi is a member of the Leukemia and Lymphoma section. His other area of special interest is Hemophagocytic Lymphohistiocytosis (HLH). He has previously served as the head of the in-patient oncology section. He has been closely involved with the Paediatric Haematology and Oncology Education Program at SickKids and the University of Toronto. He was the Director of this program from 2006 to 2008 and is currently the Associate Director in charge of the clinical fellowship.
Dr. Naqvi is a member of the Histiocyte Society (HS), American Society of Hematology (ASH), International Society of Pediatric Haematology and Oncology (SIOP), Pakistan Pediatric Association (PPA) and Pakistan Society of Paediatric Oncology (PSPO).
Paediatric Hematology/Oncology Fellowship
The Hospital for Sick Children, 1995-1998
- Hemophagocytic Lymphohistiocytosis (HLH)
- Medical education
- Inpatient care of children with leukemia and lymphoma and Hemophagocytic Lymphohistiocytosis (HLH)
- Ontario Cancer Research Network
- Glaxo-Smith Kline Inc.
- OSI Pharmaceuticals, Inc.
Click here for current listings from PubMed.